The study of the human microbiome remains one of the most exciting frontiers in modern medicine that if targeted correctly, has the potential to benefit millions of patients suffering from numerous diseases. However, the potential for effective medicines powered by the microbiome is matched by the unique challenges in developing them.

The Microbiome Movement – Drug Development Summit returns as the “must attend meeting for the translational microbiome community” to help cutting-edge pharmaceutical and academic researchers pursue the causal role of the human microbiome in disease to help deliver a new generation of targeted therapeutics, biomarker and diagnostics that demonstrate consistent clinical outcomes and predictabe MoAs.

So whether you’re part of a microbiome-focused biotech, a pharmaceutical organization assessing this exciting field, or an academic researcher with breakthrough findings, join the Microbiome Movement as we explore the global advances in translational microbiome research, and meet like-minded peers who are continuing to understand the causal and therapeutic potential of the ‘second genome’.

Click here to learn more.
Click here to view the agenda.
Click here to register.